Mumbai, Apr 8 () Shares of Ipca Laboratories settled nearly 11 per cent lower today as Switzerland-based Global Fund, which financially supports various disease eradication programmes, will **t source malaria drug from the company. The stock slumped 10.61 per cent to settle at Rs 499.30 on BSE.